Abstract | BACKGROUND: METHODS: Transcriptome, epigenome and kinome profiling allowed a systems biology level characterisation of genomewide immunomodulatory effects of a standardized Echinacea purpurea (L.) Moench extract in THP1 monocytes. RESULTS: Gene expression and DNA methylation analysis revealed that Echinaforce® treatment triggers antiviral innate immunity pathways, involving tonic IFN signaling, activation of pattern recognition receptors, chemotaxis and immunometabolism. Furthermore, phosphopeptide based kinome activity profiling and pharmacological inhibitor experiments with filgotinib confirm a key role for Janus Kinase (JAK)-1 dependent gene expression changes in innate immune signaling. Finally, Echinaforce® treatment induces DNA hypermethylation at intergenic CpG, long/short interspersed nuclear DNA repeat elements (LINE, SINE) or long termininal DNA repeats (LTR). This changes transcription of flanking endogenous retroviral sequences (HERVs), involved in an evolutionary conserved (epi) genomic protective response against viral infections. CONCLUSIONS:
|
Authors | Ken Declerck, Claudina Perez Novo, Lisa Grielens, Guy Van Camp, Andreas Suter, Wim Vanden Berghe |
Journal | BMC complementary medicine and therapies
(BMC Complement Med Ther)
Vol. 21
Issue 1
Pg. 141
(May 12 2021)
ISSN: 2662-7671 [Electronic] England |
PMID | 33980308
(Publication Type: Journal Article)
|
Chemical References |
- Immunologic Factors
- Plant Extracts
- Interferons
|
Topics |
- Echinacea
- Gene Expression
- Humans
- Immunity, Innate
(drug effects)
- Immunologic Factors
(pharmacology, therapeutic use)
- Interferons
(drug effects)
- Monocytes
(drug effects)
- Phytotherapy
- Plant Extracts
(pharmacology, therapeutic use)
- SARS-CoV-2
(drug effects)
- COVID-19 Drug Treatment
|